AI-generated summary
The authors studied 22 breast cancer patients with radiation-induced breast telangiectasias treated with a 595 nm pulsed dye laser. Eleven of the 16 patients who reached 50% clearance completed follow-up quality-of-life questionnaires, which showed statistically significant improvements in several domains. The study was prospective but had no control group and a small sample.
- Participants
- 22
- Who or what was studied
- Female breast cancer patients (average age 56) with chronic radiation dermatitis and radiation-induced breast telangiectasias at Memorial Sloan Kettering Cancer Center
- Wavelengths
- 595 nm
- Limits stated in the abstract
- Small sample of 22 patients, no control group, and only 11 of 16 responders completed follow-up questionnaires.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 595 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.